Page last updated: 2024-10-28

lidocaine and Blue Toe Syndrome

lidocaine has been researched along with Blue Toe Syndrome in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Blue Toe Syndrome: A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without amputation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belsky, J1
Alvey, H1
Bencze, A1
Thompson, B1
Stokes-Buzzelli, S1

Other Studies

1 other study available for lidocaine and Blue Toe Syndrome

ArticleYear
Blue toe syndrome, ischemic pain treated with digital block.
    Internal and emergency medicine, 2015, Volume: 10, Issue:5

    Topics: Anesthetics, Local; Blue Toe Syndrome; Humans; Lidocaine; Male; Middle Aged; Nerve Block; Pain

2015